ÂÜÀòÂÒÂ×

Simon Allen is currently the CEO and Director at Anebulo Pharmaceuticals. Prior to this, they served as the Chief Business Officer at Ambrx from September 2010 to January 2015. In this role, they were responsible for the company's global business development strategy and identified and completed multiple technology and product focused collaborations that realized over $120M in non-dilutive revenue to date with $1.5B in potential milestones plus royalties remaining. Simon also helped establish a China strategy for drug development. From August 2006 to March 2008, they served as the VP Business Development at CovX (a subsidiary of Pfizer). And from July 2004 to February 2006, they served as the VP Business Development at Nuvelo.

Some direct reports include Rex Merchant - Chief Financial Officer, Linda Klumpers - Chief Scientific Officer.